U.S. Government Gives Moderna $176 Million to Develop mRNA Bird Flu Biologic
On July 2, 2024, the U.S. government awarded a $176 million contract to Moderna, Inc. for the development of an mRNA H5N1 avian influenza biologic labeled a “vaccine,” as the media reports concerns about bird flu in dairy cows and farm workers in multiple states. The funds from the U.S. Biomedical Advanced Research and Development […]
Pfizer Sued for Misleading Claims About Its COVID Shot
The State of Kansas has sued Pfizer, Inc. over its mRNA (messenger ribonucleic acid) COVID-19 shot, Comirnaty. Kansas attorney general Kris Kobach alleges that the pharmaceutical giant labeled and marketed the novel biologic as, “safe and effective,” while knowing that the product could cause, “serious adverse events,” including myocarditis and pericarditis, failed pregnancies and death.”1 Texas […]
Guillain-Barré Syndrome ‘More Common Than Expected’ in Early RSV Vaccine Trial
Reports of the nervous system disorder Guillain-Barré syndrome (GBS) were “more common than expected” in the older adult population who received the new vaccine for respiratory syncytial virus (RSV). The data, reported by the U.S. Centers for Disease Control and Prevention (CDC), matched trial data reported earlier this year.1 GBS is a “polio-like” inflammatory autoimmune […]
Former CDC Director Admits the Truth
Since the start of the COVID-19 pandemic in 2020, anyone who questioned lockdowns, mask mandates, the lab leak, or school closures was vilified by the media, politicians, and the “expert” community. Unproven policies without any supporting evidence, as even Dr. Anthony Fauci now admits, were suddenly immutable truths that could not be questioned. Those who […]
COVID Shots and Rise in Excess Deaths in Many Countries
A recent study published in the British medical journal The BMJ found a total of 3,089,465 “excess deaths” reported in 47 Western countries during the first three years of the COVID-19 pandemic—from Jan. 1, 2020 through Dec. 31, 2022. The study, conducted by researchers from Vrije Universiteit Amsterdam in the Netherlands, suggests that part of the […]
Moderna Stops mRNA COVID Biologics Plant Construction in Kenya
Moderna, Inc. announced recently that it has suspended its efforts to build a $200–$500 million mRNA (messenger ribonucleic acid) biologics manufacturing facility in Kenya while it determines projected future demand for mRNA biologics in Africa. Company officials concluded that, since the end of the COVID pandemic, interest in COVID-19 biologics in Kenya and Africa has […]